After struggling for a long time, it looks like we might be looking at better times for Hoth Therapeutics. Positive data from the initial clinical testing of the company's lead candidate is a great sign. I think there'll be more good news down the... — read more
Will HOTH continue to fail?
2023 wasn't a kind year for HOTH. Will 2024 be any better?